Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 39:1290-1296
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ajani, A. E.
Right arrow Articles by Kent, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ajani, A. E.
Right arrow Articles by Kent, K. M.

CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY

The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation

Andrew E. Ajani, MBBS*, Ron Waksman, MD, FACC*,*, Dong-Hun Cha, MD*, Luis Gruberg, MD*, Lowell F. Satler, MD, FACC*, Augusto D. Pichard, MD, FACC* and Kenneth M. Kent, MD, FACC*

* Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C., USA

Manuscript received May 24, 2001; revised manuscript received January 7, 2002, accepted January 18, 2002.

* Reprint requests and correspondence: Dr. Ron Waksman, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA
ron.waksman{at}medstar.net

OBJECTIVES: The study assessed the influence of lesion length and reference vessel diameter (RVD) on recurrent restenosis after gamma intracoronary radiation therapy (ICRT) for in-stent restenosis (IRS).

BACKGROUND: Intracoronary radiation therapy reduces angiographic and clinical restenosis in patients with ISR. The impact of ICRT on challenging subgroups, such as long lesions and small vessels, has not been established.

METHODS: Six-month quantitative coronary angiography and clinical follow-up were conducted to evaluate the influence of lesion length and RVD in patients with ISR treated with ICRT who were enrolled in gamma radiation trials. Angiographic binary restenosis (>50% diameter stenosis) and clinical events were assessed in 311 patients treated with gamma ICRT and 105 patients who received placebo.

RESULTS: Baseline demographic, angiographic and procedural details were similar in the two treatment groups. The ICRT group had reduced binary restenosis in vessels of all sizes (30% vs. 66%, p < 0.001), with the most benefit seen in small vessels. A trend toward reduced restenosis with ICRT was found across all lesion lengths. At six months, major adverse cardiac events (MACE) were reduced in the ICRT group compared to placebo (34% vs. 71%, p < 0.0001), driven by reduced target vessel revascularization (27% vs. 71%, p < 0.0001). The independent predictors of angiographic restenosis include ICRT (OR [odds ratio] 0.16; CI [confidence interval] 0.10 to 0.28, p < 0.001), lesion length (OR 1.03; CI 1.01 to 1.05, p = 0.004) and RVD (OR 0.40; CI 0.23 to 0.67, p < 0.001).

CONCLUSIONS: Intracoronary radiation therapy, compared to placebo, results in a significant reduction of angiographic restenosis across all vessel sizes, with a trend toward reduction of angiographic restenosis across all lesion lengths; this effect is seen predominantly in small vessels and diffuse lesions.

Abbreviations and Acronyms
  CI
  confidence interval
  ICRT
  intracoronary radiation therapy
  ISR
  in-stent restenosis
  IVUS
  intravascular ultrasound
  LTO
  late total occlusion
  LVEF
  left ventricular ejection fraction
  MACE
  major adverse cardiac events
  MI
  myocardial infarction
  MLD
  minimal luminal diameter
  OR
  odds ratio
  PTCA
  percutaneous transluminal coronary angioplasty
  QCA
  quantitative coronary angiography
  RVD
  reference vessel diameter
  SCRIPPS
  Scripps Coronary Radiation to Inhibit Proliferation Post Stenting
  TLR
  target lesion revascularization
  TVR
  target vessel revascularization
  WRIST
  Washington Radiation for In-Stent restenosis Trial




This article has been cited by other articles:


Home page
Eur Heart JHome page
L. Ge, I. Iakovou, J. Cosgrave, A. Chieffo, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, G. Melzi, G. M. Sangiorgi, et al.
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions
Eur. Heart J., June 1, 2005; 26(11): 1056 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Waksman
Reply
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 396 - 396.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement